Chilton Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Chilton Capital Management's AMGN Position: Q2 2026 in Review
Chilton Capital Management reduced its Amgen (AMGN) stake by 4.9% in Q2 2026, selling an estimated $72.2K and leaving 4,095 shares worth $1.48M. The position accounts for 0.05% of the portfolio, ranked #110.
Chilton Capital Management first reported a position in AMGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $23M in Q3 2024. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Chilton Capital Management held 4,095 shares of Amgen worth $1.48M as of Q2 2026.
- Chilton Capital Management sold 211 Amgen shares in Q2 2026, an estimated $72.2K.
- Amgen made up 0.05% of Chilton Capital Management's portfolio in Q2 2026, its #110 holding.
- Chilton Capital Management first reported a position in Amgen in Q2 2022 and has held it in 17 quarters since.
- Chilton Capital Management's Amgen position peaked at $23M in Q3 2024.
- 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.